Results for 'clinical'
Monty Pal
Breaking Barriers in Cancer Care: Expanding Access, Innovation & Integrative Medicine
City of Hope, Monty Pal, Edward Kim, integrative oncology, national clinical trial, patient access
Dr. Ed Kim shares insights on why redefining the standard of care is critical for improving patient outcomes, the future of clinical trials, and the role of integrative medicine in oncology.
Mar 21st • 33 mins listen
Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
City of Hope, Monty Pal, Walter Stadler, Alan Bryce, ASCO, national model, precision, AI, clinical trial design, dose strategy, early detection, long term survivorship
Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.
Jun 23rd • 43 mins listen
Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care
Jay Fine, Preclinical Research, Early Stage
In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.
Feb 17th • 23 mins listen
MSL Talk: Tom Caravela, Jessica Johnson, Whitney Theiss
The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)
Clinical Practice Liaison, Field Medical Positions, Medical Science Liaisons, Transition to Industry, Emotional Intelligence in Healthcare
In this episode, Jessica Johnson and Whitney Theiss from Neurocrine Biosciences join Tom Caravela to explore the transition from clinical roles to field medical positions, focusing on the Clinical Practice Liaison (CPL) role. They discuss the responsibilities and skills required for CPLs, compa…
Mar 30th • 35 mins listen
MSL Talk: Tom Caravela, Brad Atkinson, Brian Wilson, Christina Wright
How and Why Medical Affairs Can Support Diversity in Clinical Trials
diversity in clinical trials, role of MSLs, FDA guidance on diversity, patient-centric approaches, cultural awareness and allyship
In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the …
Aug 24th • 42 mins listen
MSL Talk: Tom Caravela, Ryan Norman
Engagement Strategies: Crafting Your Story to Clinical Professionals
pharmaceutical industry, clinical expertise, business insights, MSL role, virtual engagements
In this episode, Ryan Norman joins Tom Caravela to discuss his journey into the pharmaceutical industry and how he successfully blended clinical expertise with business insights in his role as an MSL. Ryan delves into effective strategies for preparing for KOL meetings, aligning messaging with …
Sep 14th • 31 mins listen
MSL Talk: Tom Caravela, Carrie Caretta, Giancarlo Maranzano
The Misalignment of Clinical Development and Field Medical Affairs
clinical development, field medical affairs, MSLs recruitment, pharmaceutical strategies, Boehringer Ingelheim
In this episode, Tom Caravela is joined by Carrie Caretta and Giancarlo Maranzano from Boehringer Ingelheim to explore the integration of clinical development and field medical affairs. They discuss the strategic role of field medical teams in clinical trial recruitment and how MSLs can effecti…
Mar 22nd • 29 mins listen
MSL Talk: Tom Caravela, Khalil Ahmed
Evolving Role of MSL Field Support for Clinical Trials
Medical Science Liaisons, clinical trials, MSL involvement, Syneos Health, Khalil Ahmed
In this episode, Tom Caravela is joined by Khalil Ahmed to explore the integral role of Medical Science Liaisons (MSLs) in clinical trials. Khalil shares his background and discusses the significant impact MSLs have on site selection, recruitment, and training. The conversation delves into the …
Apr 4th • 34 mins listen
MSL Talk: Tom Caravela, Michelle Offner
The Evolving Role of Clinical Educators for Pharma and Field Medical
clinical educator, medical field, clinical education, networking, health outcomes
In this episode, Michelle Offner shares her journey from her previous roles to becoming a clinical educator. She delves into the responsibilities and importance of clinical educators, highlighting the skills and value they bring to the medical field. Michelle discusses the challenges faced in this r…
Sep 17th • 26 mins listen
MSL Talk: Tom Caravela, Jeff Vaughn, Dean McAllister
Is it Ever Too Early or Too Late
Medical Science Liaison, drug development, early MSL engagement, clinical trial planning, strategic prioritization
In this episode, Tom Caravela is joined by Jeff Vaughn and Dean McAllister to discuss the critical timing of Medical Science Liaison (MSL) involvement in drug development. They explore misconceptions and historical approaches, highlighting the impact and internal value of early MSL engagement. The c…
Feb 18th • 34 mins listen
MSL Talk: Tom Caravela, Maria Abunto
From Clinical to Medical Device MSL and Beyond
Medical Science Liaison, MSL roles, medical device industry, transitioning MSL, International MSL Day
In this episode, Maria Abunto joins Tom Caravela to discuss her journey from clinical practice to becoming a successful Medical Science Liaison (MSL) in the medical device industry. Maria shares insights on why clinicians are well-suited for MSL roles and the importance of mentors and career co…
Apr 20th • 28 mins listen
Cancer Buzz Podcast
IO Clinical Trials During COVID-19
On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …
Jun 23rd • 13 mins listen
Cancer Buzz Podcast
Improving Community Clinical Trial Participation
Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioriti…
Oct 13th • 6 mins listen
Cancer Buzz Podcast
Increasing Clinical Trial Access for Blood Cancers
Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinkin…
Jun 7th • 19 mins listen
Cancer Buzz Podcast
The Role of the Clinical Trials Navigator
Adding a clinical trials navigator to this practice team required a business case that demonstrated return on investment. After a successful onboarding, this navigator is now the point person to help identify patients appropriate for clinical trials and to help busy clinicians with enrollment crit…
Aug 29th • 6 mins listen
Cancer Buzz Podcast
Clinical Trial Access in Rural Areas
Clinical trials are crucial to cancer research and are often standard of care for patients with cancer, but for patients in rural areas, accessing clinical trials poses significant geographic and financial barriers. On this episode, we learn how Sanford Health harnessed its passion and creativity …
Oct 16th • 24 mins listen
Cancer Buzz Podcast
Advancing Clinical Trial Equity
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…
Jun 25th • 8 mins listen
Journal of Clinical Oncology (JCO) Podcast
The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
This podcast discusses whether the primary outcomes and study design for the reported trial were properly pre-specified and pre-registered prior to accruing participants.
Jan 24th • 12 mins listen
ournal of Clinical Oncology (JCO) Podcast
How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
This podcast considers the impact of exclusion criteria on clinical trials, generalizability, and the complexity of modernizing eligibility while maintaining trial integrity.
Mar 25th • 10 mins listen
Journal of Clinical Oncology (JCO) Podcast
ctDNA in DLBCL: A Blueprint for Better Clinical Trials?
Current clinical characteristics and demographics are not sufficient to capture aggressive disease in clinical trials of newly diagnosed DLBCL. Novel tools, such as measurement of tumor burden via ctDNA, are needed. By : Dr. Matthew Maurer.
Apr 10th • 7 mins listen